Science Corporation implants PRIMA vision chip in first Stargardt disease patient

Science Corporation, led by Neuralink co-founder Max Hodak, announced the first implantation of its PRIMA vision-restoring chip in a patient with Stargardt disease. The implant bypasses damaged photoreceptors and delivers visual information directly to the brain via a brain-computer interface.

• PRIMA is a BCI implant designed to restore vision in retinal degeneration
• The procedure was performed on a Stargardt disease patient in October 2026
• The company is led by Neuralink co-founder Max Hodak